Insider Transactions in Q2 2022 at Haemonetics Corp (HAE)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 13
2022
|
Simon, Christopher President & CEO |
SELL
Open market or private sale
|
Direct |
1,148
-0.53%
|
$71,176
$62.6 P/Share
|
Jun 13
2022
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
277
-0.68%
|
$17,174
$62.6 P/Share
|
Jun 13
2022
|
Dan Goldstein VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
42
-0.94%
|
$2,604
$62.6 P/Share
|
Jun 13
2022
|
Laurie A. Miller SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
30
-0.23%
|
$1,860
$62.6 P/Share
|
Jun 02
2022
|
Laurie A. Miller SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
198
-1.5%
|
$12,276
$62.69 P/Share
|
Jun 02
2022
|
Dan Goldstein VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
249
-5.26%
|
$15,438
$62.69 P/Share
|
May 19
2022
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
3,258
-7.38%
|
$192,222
$59.1 P/Share
|
May 19
2022
|
Dan Goldstein VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
134
-2.75%
|
$7,906
$59.1 P/Share
|
May 19
2022
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,384
-7.4%
|
$81,656
$59.1 P/Share
|
May 19
2022
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
1,418
-7.56%
|
$83,662
$59.1 P/Share
|
May 19
2022
|
Laurie A. Miller SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
91
-0.69%
|
$5,369
$59.1 P/Share
|
May 19
2022
|
Simon, Christopher President & CEO |
SELL
Open market or private sale
|
Direct |
2,496
-1.15%
|
$147,264
$59.1 P/Share
|
May 19
2022
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
1,084
-6.44%
|
$63,956
$59.1 P/Share
|
May 16
2022
|
Simon, Christopher President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
26,041
+10.7%
|
-
|
May 16
2022
|
Simon, Christopher President & CEO |
SELL
Open market or private sale
|
Direct |
832
-0.43%
|
$46,592
$56.1 P/Share
|
May 16
2022
|
James D Arecca EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,774
+30.9%
|
-
|
May 16
2022
|
Michelle L Basil EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,076
+12.09%
|
-
|
May 16
2022
|
Michelle L Basil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
196
-0.51%
|
$10,976
$56.1 P/Share
|
May 16
2022
|
Dan Goldstein VP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
868
+15.12%
|
-
|
May 16
2022
|
Dan Goldstein VP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
50
-1.23%
|
$2,800
$56.1 P/Share
|
May 16
2022
|
Anila Lingamneni EVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,340
+18.83%
|
-
|
May 16
2022
|
Josep Llorens EVP, Global Manufacturing |
BUY
Grant, award, or other acquisition
|
Direct |
4,340
+18.79%
|
-
|
May 16
2022
|
Josep Llorens EVP, Global Manufacturing |
SELL
Open market or private sale
|
Direct |
107
-0.74%
|
$5,992
$56.1 P/Share
|
May 16
2022
|
Laurie A. Miller SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
3,038
+18.63%
|
-
|
May 16
2022
|
Laurie A. Miller SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
31
-0.3%
|
$1,736
$56.1 P/Share
|
May 16
2022
|
Stewart W Strong President, Global Hospital |
BUY
Grant, award, or other acquisition
|
Direct |
4,123
+19.67%
|
-
|
May 02
2022
|
James D Arecca EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,902
+50.0%
|
-
|
Apr 18
2022
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
189
-1.33%
|
$10,584
$56.55 P/Share
|